At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Glycaemia, Insulin Secretion and Action in Morbidly Obese Subjects With Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study
In Brief
A clinical study evaluating Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy, Sleeve gastrecomy, and 1 other intervention for Type 2 Diabetes and Morbid Obesity. Completed, enrolled 125 participants across 1 site.
Detailed Summary
Glycaemia, insulin secretion and action in morbidly obes subjects with type 2 diabetes after sleeve gastrectomy ond Roux-en-Y gastric bypass: A randomised single centre study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes, Morbid Obesity
CountriesNorway
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedJan 2013
Primary CompletionJan 2019
Study CompletionNov 2022
TodayJul 2026
First PostedJan 29, 2013
Enrollment StartJan 1, 2013
Primary CompletionJan 1, 2019
Study CompletionNov 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 13.4 years ago
Interventions
Bariatric surgery, either gastric bypass surgery or sleeve gastrectomyprocedure
Vertical sleeve gastrectomy or a gastric bypass surgery in morbidly obese individuals with type 2 diabetes. Random allocation to surgical intervention
Sleeve gastrecomyprocedure
Vertical sleeve gastrectomy
Bastric bypassprocedure
Gastric bypass surgery